TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon 

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Abiomed; AstraZenca; Bayer AG; Daiichi-Sankyo/Elil Lilly and Company; SIS Medical; Boehringer Ingelheim; Novartis
• Grant Support/Research Contract - Abbott Vascular; Vifor; SIS Medical; Biosensors